Trademarkia Logo

Canada

C$
CARBOSYNTH
REGISTERED

on 20 Apr 2022

Last Applicant/ Owned by

BIOSYNTH AG

P.O. Box 125CH-9422 Staad

CH

Serial Number

2012728 filed on 21st Nov 2019

Registration Number

TMA1126253 registered on 20th Apr 2022

Registration expiry Date

21st Nov 2029

Correspondent Address

ANNA CLARK

(DENTONS CANADA LLP)99 Bank StreetSuite 1420Ottawa

ONTARIO

CA

K1P1H4

CARBOSYNTH

Trademark usage description

biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidon Read More

Classification Information


Class [001]
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, and cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics.


Classification kind code

11

Class [005]
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; chemical reagents for medical and veterinarian use, namely, diagnostic reagents for medical and veterinary diagnostic use, diagnostic reagents for medical and veterinary laboratory use, and diagnostic reagents for medical and veterinary research; chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain escherichia coli o157:h7; chemical preparations for medical purposes, namely, for cholesterol testing to prevent possible consequences of hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of listeria, clostridium, bacillus and staphylococcus; chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of escherichia coli; medical preparations for the diagnosis of staphylococus aureus, in particular for methicillin-resistant staphylococcus aureus (mrsa); chemical reagents for medical research use in the field of immunology; chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms.


Classification kind code

11

Mark Details


Serial Number

2012728

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 18th Oct 2021
Agent Changed
Submitted for opposition 22
on 17th Jun 2021
Search Recorded
Submitted for opposition 20
on 17th Jun 2021
Examiner's First Report
Submitted for opposition 223
on 17th Jun 2021
Total Provisional Refusal
Submitted for opposition 256
on 21st Dec 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 20th Feb 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Feb 2020
Created
Submitted for opposition 31
on 19th Feb 2020
Formalized
Submitted for opposition 228
on 21st Nov 2019
International Registration
Submitted for opposition 30
on 21st Nov 2019
Filed